Why is P & G Health Ltd falling/rising?

As of 21-Aug, Procter & Gamble Health Ltd's stock price is rising, currently at 6,349.75, reflecting an increase of 70.75 or 1.13%. The stock is trading close to its 52-week high, just 2.21% away from Rs 6,490, and has outperformed its sector by 0.67% today. Additionally, it is trading above all its moving averages, indicating a strong upward trend. Over the past month, the stock has shown a return of 8.22%, significantly outperforming the Sensex, which has declined by 0.24%. The company has demonstrated high management efficiency with a return on equity (ROE) of 32.32% and has maintained a low debt-to-equity ratio, which supports its positive performance. Furthermore, the company has reported positive results for the last four consecutive quarters, contributing to investor confidence.
In the broader market context, while the stock has generated a 17.98% return over the past year, the benchmark BSE500 has seen negative returns of -1.56%, highlighting the stock's strong performance relative to the market. However, there are concerns regarding its long-term growth, as net sales have only grown at an annual rate of 7.39% over the last five years. Despite a high valuation indicated by a price-to-book ratio of 19.6, the stock is trading at a discount compared to its peers. The recent decline in investor participation, with a significant drop in delivery volume, could pose a risk to its upward momentum, but the high institutional holdings suggest that informed investors continue to support the stock.